Specielt ved depotprodukter (Nifedipine Pharmamatch retard) skal udskillelsen være så komplet som muligt, inkl. tyndtarmen, for at forhindre anden uundgåelig efterfølgende absorption af det aktive stof.
Especially for prolonged-release products (Nifedipine Pharmamatch retard) elimination must be as complete as possible, including the small intestine, to prevent the otherwise inevitable subsequent absorption of the active substance.